Asgard Therapeutics

Asgard Therapeutics is at the forefront of biotechnology research, pioneering innovative approaches to cancer immunotherapy. With a focus on direct cell reprogramming technologies, Asgard Therapeutics is dedicated to developing groundbreaking therapies that harness the power of the immune system to combat cancer. The company operates from its primary location in Lund, Sköna 221 84, SE, driving advancements in personalized cancer treatments.

Asgard Therapeutics is developing a gene therapy approach based on its proprietary TrojanDC technology, designed to initiate robust immune responses by leveraging the biological properties of professional antigen-presenting cells. The company's commitment to innovation and scientific excellence positions it as a key player in the future of cancer treatment.

Asgard Therapeutics is dedicated to advancing the field of cancer immunotherapy and improving patient outcomes. We invite the manager of Asgard Therapeutics to create a customized and exclusive company showcase and product listing on our platform to further highlight their contributions and connect with a broader audience.